Overview

Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.
Phase:
Phase 2
Details
Lead Sponsor:
EmeraMed
Ermes Medical Company Ltd
Collaborators:
NBMI Science AB
NBMI Science AB (Subsidiary of Ermes Medical Company Ltd)
Treatments:
N,N'-Bis(2-mercaptoethyl)isophthalamide